Christopher M Starr insider trades: Monopar Therapeutics (MNPR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | MNPR | ↓ Sell | 8,400 | $78.50 | $659K | Direct | Oct 5, 2026 (4d) |
| Jul 14, 2025 | MNPR | ↓ Sell | 16,800 | $40.00 | $672K | Direct | Jul 16, 2025 (2d) |
| Mar 23, 2015 | RPTP | ↓ Sell | 20,033 | $11.62 | $233K | Direct | Mar 25, 2015 (2d) |
| Mar 16, 2015 | RPTP | ↓ Sell | 30,021 | $11.71 | $352K | Direct | Mar 18, 2015 (2d) |
| Feb 24, 2015 | RPTP | ↓ Sell | 30,000 | $9.52 | $286K | Direct | Feb 25, 2015 (1d) |
| Feb 17, 2015 | RPTP | ↓ Sell | 30,000 | $9.37 | $281K | Direct | Feb 19, 2015 (2d) |
| Jan 22, 2015 | RPTP | ↓ Sell | 30,000 | $9.45 | $284K | Direct | Jan 26, 2015 (4d) |
| Jan 15, 2015 | RPTP | ↓ Sell | 30,000 | $9.73 | $292K | Direct | Jan 20, 2015 (5d) |
| Dec 22, 2014 | RPTP | ↓ Sell | 30,000 | $9.00 | $270K | Direct | Dec 23, 2014 (1d) |
| Dec 15, 2014 | RPTP | ↓ Sell | 30,000 | $8.15 | $245K | Direct | Dec 17, 2014 (2d) |
| Nov 24, 2014 | RPTP | ↓ Sell | 30,000 | $9.97 | $299K | Direct | Nov 25, 2014 (1d) |
| Nov 17, 2014 | RPTP | ↓ Sell | 30,000 | $9.91 | $297K | Direct | Nov 19, 2014 (2d) |
| Oct 22, 2014 | RPTP | ↓ Sell | 30,000 | $10.25 | $307K | Direct | Oct 24, 2014 (2d) |
| Oct 15, 2014 | RPTP | ↓ Sell | 30,000 | $10.04 | $301K | Direct | Oct 17, 2014 (2d) |
| Sep 23, 2014 | RPTP | ↓ Sell | 30,000 | $10.21 | $306K | Direct | Sep 25, 2014 (2d) |
| Sep 16, 2014 | RPTP | ↓ Sell | 32,896 | $10.60 | $349K | Direct | Sep 18, 2014 (2d) |
| Mar 17, 2014 | RPTP | ↓ Sell | 19,316 | $10.79 | $208K | Direct | Mar 19, 2014 (2d) |
| Feb 18, 2014 | RPTP | ↓ Sell | 25,000 | $15.26 | $382K | Direct | Feb 20, 2014 (2d) |
| Jan 15, 2014 | RPTP | ↓ Sell | 25,000 | $15.42 | $385K | Direct | Jan 17, 2014 (2d) |
| Dec 16, 2013 | RPTP | ↓ Sell | 25,000 | $13.36 | $334K | Direct | Dec 18, 2013 (2d) |
| Nov 15, 2013 | RPTP | ↓ Sell | 25,000 | $12.31 | $308K | Direct | Nov 19, 2013 (4d) |
| Oct 15, 2013 | RPTP | ↓ Sell | 25,000 | $13.77 | $344K | Direct | Oct 17, 2013 (2d) |
| Sep 16, 2013 | RPTP | ↓ Sell | 25,000 | $14.21 | $355K | Direct | Sep 18, 2013 (2d) |
| Dec 31, 2012 | RPTP | ↓ Sell | 10,088 | $5.68 | $57K | Direct | Jan 2, 2013 (2d) |
| Sep 28, 2012 | RPTP | ↓ Sell | 10,085 | $5.39 | $54K | Direct | Oct 1, 2012 (3d) |
| Jun 29, 2012 | RPTP | ↓ Sell | 10,085 | $5.60 | $56K | Direct | Jul 2, 2012 (3d) |
| Apr 2, 2012 | RPTP | ↓ Sell | 10,085 | $6.72 | $68K | Direct | Apr 4, 2012 (2d) |
| Dec 1, 2005 | BMRN | ↓ Sell | 10,571 | $10.00 | $106K | Direct | Dec 2, 2005 (1d) |
| Nov 21, 2005 | BMRN | ↓ Sell | 10,571 | $10.00 | $106K | Direct | Nov 23, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MNPR insiders
Open-market trades in the last 12 months
About Christopher M Starr's insider trades
Christopher M Starr is a director at Monopar Therapeutics (MNPR). Since Nov 21, 2005, Christopher has reported no open-market purchases and 29 sales worth $8.2M on SEC Form 4. In the last 12 months: 1 sale ($659K).
Their filings also include option exercises (44 filings), grants and awards (18 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.